Aphria gets official approval in Germany for a cannabis cultivation license – New Cannabis Ventures

LEAMINGTON, ON, April 5, 2019 / PRNewswire / – Aphria Inc. ("Aphria" or "the Company") (TSX: APHA and NYSE: APHA) today announced that its German subsidiary Aphria Deutschland GmbH (" Aphria Germany ") was selected by the German Federal Institute for Drugs and Medical Devices (" BfArM ") to receive a license to cultivate cannabis for medical purposes in the country. The interim decision announced by BfArM is subject to a mandatory 10-day standstill period for public procurement (the "status quo"), which allows unsuccessful bidders to challenge the decision before the final contract is signed. BfArM's decision would grant Aphria 5 of the 13 available lots, each with a minimum annual capacity of 200 kg.

Aphria is proud to have been selected as the successful bidder in the German bid process, which demonstrates our high production quality standards, "said Hendrik Knopp, general manager of 39; Aphria Germany. "BfArM's decision is a validation of our strategic approach to support the German market for medical cannabis, including high-quality domestic production to ensure a vital supply for patients. We are very pleased with the continuation of our commercial momentum in Germany. "

Since the promulgation of the German cannabis law as a drug in March 2017, the country's growing need for medical cannabis, currently estimated at 40,000 patients, has been provided exclusively by imports. In anticipation of the completion of Standstill, Aphria hopes to be able to provide German patients with high quality medical cannabis cultivated in the country.

We have good things that grow

About Aphria

Aphria is a global leader in the cannabis industry, driven by an unwavering commitment to our people, the quality of its products and innovation. Aphria, headquartered in Leamington, Ontario – Canada's greenhouse capital – has set the standard for low-cost, safe, clean and pure pharmaceutical grade cannabis production grown under the most natural conditions. possible. Focusing on untapped opportunities and relying on the latest technology, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company's brand portfolio is based on in-depth consumer knowledge designed to meet the needs of all consumer segments. Rooted in the multigenerational know-how of our founders in commercial agriculture, Aphria delivers long-term, sustainable shareholder value through a diversified approach to innovation, strategic partnerships, and global expansion, with a focus on presence in more than 10 countries on 5 continents.

For more information, visit: aphria.ca

Original press release

Posted by NCV Newswire

NCV Newswire of New Cannabis Ventures aims to provide high quality content and information on leading cannabis producing companies to help our readers filter noise and stay current on the most important news stories. cannabis. NCV Newswire is hand-crafted by an editor and is by no means automated. Do you have confidential advice? Get in touch.